SIGYN THERAPEUTICS, INC. (SIGY) Operating cash flow 2014–2024
SIGYN THERAPEUTICS, INC. (SIGY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$872,436FY2024 · since FY2014: -$44,440 → -$872,436
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$872,436 | +36.9% |
| FY2023 | -$1.4M | +24.4% |
| FY2022 | -$1.8M | -3.2% |
| FY2021 | -$1.8M | -113.8% |
| FY2020 | -$829,809 | -477.5% |
| FY2019 | -$143,684 | +49.8% |
| FY2018 | -$286,112 | +28.5% |
| FY2017 | -$400,003 | — |
| FY2015 | -$83,820 | -88.6% |
| FY2014 | -$44,440 | — |
Source: SEC XBRL filings · For reference only · Not investment advice